Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PRE
PRE logo

PRE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Prenetics Global Ltd (PRE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
18.140
1 Day change
1.74%
52 Week Range
23.630
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Prenetics Global Ltd (PRE) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown significant revenue growth and has streamlined its operations to focus on its IM8 brand, the technical indicators and trading signals do not support an immediate entry. Additionally, the stock's recent performance and lack of significant positive catalysts suggest waiting for a clearer entry point.

Technical Analysis

The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 37.565, and moving averages are converging, suggesting no clear trend. The stock is trading near its support level of 17.48, with resistance at 18.854. Overall, the technical indicators do not suggest a strong buy signal.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
6

Positive Catalysts

  • The company has divested non-core assets, generating $150M in proceeds and simplifying its operations. IM8, the company's focus brand, has scaled to over $100M in revenue and shows potential for growth. Analysts have given buy ratings with price targets significantly above the current price.

Neutral/Negative Catalysts

  • No significant trading trends from hedge funds or insiders. The stock has a 70% chance of declining in the short term based on historical patterns. No recent news or significant event-driven catalysts. Financials, while improving, still show negative net income and EPS.

Financial Performance

In Q4 2025, revenue increased by 248.57% YoY to $36.56M, and gross margin improved to 59.47%. However, net income remains negative at -$28.12M, albeit improving by 72.05% YoY. EPS also remains negative at -1.75, though it has improved by 36.72% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts from Lake Street and Roth Capital have initiated coverage with buy ratings and price targets of $29 and $36, respectively. They highlight the company's focus on its IM8 brand and its growth potential, which is underappreciated at current levels.

Wall Street analysts forecast PRE stock price to rise
Analyst Rating
0
Wall Street analysts forecast PRE stock price to rise
Buy
Hold
Sell
0
Current: 17.830
sliders
Low
0
Averages
0
High
0
0
Current: 17.830
sliders
Low
0
Averages
0
High
0
Lake Street
initiated
$29
AI Analysis
2026-03-16
Reason
Lake Street
Price Target
$29
AI Analysis
2026-03-16
initiated
Reason
Lake Street initiated coverage of Prenetics with a Buy rating and $29 price target. Having divested three non-core assets, ACT Genomics, Europa, and its remaining stake in Insighta, Prenetics has generated more than $150M in proceeds while removing businesses that contributed little profitability and added operational complexity while shifting from a multi-division diagnostics and healthcare services company to a focused consumer health platform centered on its IM8 nutrition brand, the analyst tells investors.
Roth Capital
George Kelly
Buy
initiated
$36
2026-02-11
Reason
Roth Capital
George Kelly
Price Target
$36
2026-02-11
initiated
Buy
Reason
Roth Capital analyst George Kelly initiated coverage of Prenetics with a Buy rating and $36 price target. The company has "struggled to find its footing" after completing its business combination with SPAC Artisan Acquisition but has "found a winner" in complement brand IM8," the analyst tells investors in a research note. The firm says IM8 has quickly scaled to over $100M in revenue and has now become management's sole focus. Roth says IM8's growth potential is underappreciated at current share levels.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PRE
Unlock Now

People Also Watch